Supreme Court Could Curtail Mifepristone Access, Lay Out ‘Road Map’ To Challenge FDA Approvals

 
• By Brenda Sandburg
  
Supreme Court long shot
US Supreme Court to decide whether FDA should not have eased restrictions on access to mifepristone • Source: Brenda Sandburg

More from US FDA

More from Agency Leadership